Unravelling role of crocin for the treatment of Alzheimer’s and Parkinson’s disease: sojourn from food to nanomedicine

Kaur, Harmanpreet; Bashir, Bushra; Kaur, Amandeep; Singh, Navneet; Vishwas, Sukriti; Kumar, Puneet; Dureja, Harish; Chaitanya, Motamarri Venkata Naga Lalitha; Singh, Thakur Gurjeet; Gupta, Gaurav; Alam, Aftab; Veiga, Francisco; Paiva-Santos, Ana Cláudia; Dua, Kamal; Singh, Sachin Kumar

doi:10.1007/s11101-024-09936-w

Cited by 1 publication

(1 citation statement)

References 105 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Natural products and phytochemicals for PD therapy have garnered significant attention due to their potential to reduce the side effects of chemical medications. Naringenin, curcumin, saffron, and crocin are herbal compounds that have shown neuroprotective profiles in PD models via their antioxidant, antidepressant, and anti-inflammatory properties, hindering α-synuclein fibrillation. − The potential neuroprotective activities of SA have also been observed in PD models. Administration of SA in rat models induced by 6-hydroxydopamine (OHDA-6) led to improved turning behavior, prevented SNC dopaminergic neuron destruction, reduced iron reactions, and increased levels of MDA and nitrites when compared to the effects of apomorphine after surgery .…”

Section: Sinapic Acid’s Mechanisms Of Actionmentioning

confidence: 99%

Pharmacological Activities and Molecular Mechanisms of Sinapic Acid in Neurological Disorders

Farzan,

Abedi,

Bhia

et al. 2024

ACS Chem. Neurosci.

View full text Add to dashboard Cite

Sinapic acid (SA) is a phenylpropanoid derivative found in various natural sources that exhibits remarkable versatile properties, including antioxidant, anti-inflammatory, and metalchelating capabilities, establishing itself as a promising candidate for the prevention and treatment of conditions affecting the central nervous system, such as Alzheimer's disease (AD), Parkinson's disease (PD), ischemic stroke, and other neurological disorders. These effects also include neuroprotection in epilepsy models, as evidenced by a reduction in seizure-like behavior, cell death in specific hippocampal regions, and lowered neuroinflammatory markers. In AD, SA treatment enhances memory, reverses cognitive deficits, and attenuates astrocyte activation. SA also has positive effects on cognition by improving memory and lowering oxidative stress. This is shown by lower levels of oxidative stress markers, higher levels of antioxidant enzyme activity, and better memory retention. Additionally, in ischemic stroke and PD models, SA provides microglial protection and exerts anti-inflammatory effects. This review emphasizes SA's multifaceted neuroprotective properties and its potential role in the prevention and treatment of various brain disorders. Despite the need for further research to fully understand its mechanisms of action and clinical applicability, SA stands out as a valuable bioactive compound in the ongoing quest to combat neurodegenerative diseases and enhance the quality of life for affected individuals.

show abstract